Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung Cancer

This study has been completed.
Information provided by (Responsible Party):
Transgene Identifier:
First received: December 22, 2006
Last updated: July 15, 2014
Last verified: July 2014